Validated Genomics-Based and Clinical-Grade Diagnosis Support Systems
65,000+
International Cases Served ( Malignant & Benign ) using Genomics, Flow-Cytometry, CBC, and Blood Smear
Requests for disease diagnosis or follow-up after treatment
Test Selection Advisor assists here
Samples used for CBC with or without genomic testing
Hematopathologists examine smears and review clinical data
Automated Blood Cells Analysis assists herePublished in Nature Scientific Data through rigorous validation:
Seamless LIS/EHR Integration delivering immediate operational value:
“Achieved the quality of senior hematopathologists in NYC”
“Increased productivity in labs by up to 200%”
“Reduced time for comprehensive diagnosis report from 10-20 minutes to 2 minutes”
“Assisted in training junior physicians”
“Helped overcome shortage in the lab”
“Prevented medical errors”
“Increased profitability and reduced costs”
Get started with our diagnostic system
Enter the results of CBC, smear review, genetic tests, and clinical findings to receive a comprehensive clinicopathologic correlation (including diagnosis, prognosis, and recommendations) for Hematologic neoplasms and benign diseases, offering a perfect, personalized, and prognostic assessment with the quality of specialists in Hematopathology in New York
Clinically validated accuracy
Referencing the WHO 5th edition, the International Consensus Classification of Myeloid Neoplasms and Acute Leukemias, and other esteemed publications, 40 specialists and consultants from various international medical centers rigorously validated the medical and clerical accuracy, confirming 100% alignment with final Hematopathology reports
Zero risk data security
There is zero risk as no patient or user information is required. No one can differentiate whether the generated diagnosis is for real cases, training purposes, or hypothetical patients
Excellence in Diagnostics Across Borders
